CATALANO, GIANFRANCO
 Distribuzione geografica
Continente #
NA - Nord America 11.249
AS - Asia 1.348
EU - Europa 1.301
SA - Sud America 198
Continente sconosciuto - Info sul continente non disponibili 101
AF - Africa 20
OC - Oceania 2
Totale 14.219
Nazione #
US - Stati Uniti d'America 11.199
SG - Singapore 609
CN - Cina 305
DE - Germania 286
IT - Italia 261
RU - Federazione Russa 174
BR - Brasile 164
UA - Ucraina 141
IE - Irlanda 115
VN - Vietnam 105
HK - Hong Kong 102
GB - Regno Unito 79
FR - Francia 67
BD - Bangladesh 59
FI - Finlandia 48
KR - Corea 44
JP - Giappone 32
SE - Svezia 29
NL - Olanda 24
IN - India 22
PL - Polonia 22
CA - Canada 19
BE - Belgio 14
ID - Indonesia 14
MX - Messico 14
AR - Argentina 11
ES - Italia 11
TR - Turchia 10
ZA - Sudafrica 10
IQ - Iraq 9
EC - Ecuador 8
GR - Grecia 7
PK - Pakistan 6
AT - Austria 4
CH - Svizzera 4
CR - Costa Rica 4
KZ - Kazakistan 4
LT - Lituania 4
PH - Filippine 4
UZ - Uzbekistan 4
CL - Cile 3
CO - Colombia 3
CZ - Repubblica Ceca 3
DZ - Algeria 3
JM - Giamaica 3
PE - Perù 3
RO - Romania 3
SA - Arabia Saudita 3
UY - Uruguay 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AU - Australia 2
AZ - Azerbaigian 2
EU - Europa 2
GT - Guatemala 2
HU - Ungheria 2
JO - Giordania 2
PY - Paraguay 2
QA - Qatar 2
SV - El Salvador 2
TH - Thailandia 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
AE - Emirati Arabi Uniti 1
AO - Angola 1
DK - Danimarca 1
DM - Dominica 1
DO - Repubblica Dominicana 1
EG - Egitto 1
GE - Georgia 1
GF - Guiana Francese 1
HN - Honduras 1
IR - Iran 1
KN - Saint Kitts e Nevis 1
KW - Kuwait 1
MA - Marocco 1
MD - Moldavia 1
MY - Malesia 1
NG - Nigeria 1
NP - Nepal 1
OM - Oman 1
RS - Serbia 1
TW - Taiwan 1
TZ - Tanzania 1
Totale 14.122
Città #
Woodbridge 3.204
Wilmington 2.705
Houston 2.473
Singapore 379
Fairfield 274
Ann Arbor 234
Ashburn 226
Chandler 206
San Jose 156
Seattle 134
Jacksonville 127
Beijing 104
Dublin 102
Hong Kong 101
Cambridge 100
Council Bluffs 97
New York 82
Rome 80
Medford 76
Santa Clara 68
Dearborn 61
Dallas 54
Los Angeles 50
Zhengzhou 50
Lawrence 36
Buffalo 32
Hanoi 31
The Dalles 31
Moscow 30
Ho Chi Minh City 27
Tokyo 24
Lauterbourg 23
San Diego 22
Milan 18
Colorado Springs 17
Menlo Park 17
Mülheim 17
Nuremberg 15
Phoenix 15
Helsinki 14
Orem 14
São Paulo 14
Brussels 13
Chicago 13
Munich 13
Warsaw 13
Chennai 12
Jakarta 12
Shanghai 12
London 10
Norwalk 9
Perugia 9
Boardman 8
Brooklyn 8
Nürnberg 8
Falls Church 7
Johannesburg 7
Mountain View 7
Oxford 7
Secaucus 7
Amsterdam 6
Belo Horizonte 6
Curitiba 6
Haiphong 6
Hefei 6
Mexico City 6
Naples 6
Poplar 6
Redondo Beach 6
University Park 6
Verona 6
Atlanta 5
Guangzhou 5
Kunming 5
Manchester 5
Montreal 5
Stockholm 5
Athens 4
Biên Hòa 4
Brescia 4
Columbus 4
Frankfurt am Main 4
Istanbul 4
Kingston 4
La Veta 4
Nanchang 4
Paris 4
Pisa 4
Querétaro 4
Redwood City 4
Salt Lake City 4
Seoul 4
Springfield 4
Baghdad 3
Benxi 3
Boston 3
Bắc Ninh 3
Calgary 3
Charlotte 3
Creede 3
Totale 11.896
Nome #
A microgranular variant of acute promyelocytic leukemia with atypical morpho-cytochemical features and an early myeloid immunophenotype 537
A case of SRSF2 mutation in chronic lymphocytic leukemia 519
Possibility of long-term remission in patients with advanced hematologic malignancies after reduced intensity conditioning regimen (RIC) and allogeneic stem cell transplantation 500
Identification of a potential topoisomerase II “hotspot” DNA region in the DEK gene in two t(6;9)-positive therapy-related myeloid neoplasms 490
Development of a High-Resolution Melting Curve Analysis Screening Test for SRSF2 Splicing Factor Gene Mutations in Myelodysplastic Syndromes 472
Pyrrolo[1,2-b][1,2,5]benzothiadiazepines (PBTDs): A new class of agents with high apoptotic activity in chronic myelogenous leukemia K562 cells and in cells from patients at onset and who were imatinib-resistant 460
PML/RARa inhibits PTEN expression in hematopoietic cells by competing with PU.1 transcriptional activity 459
Imatinib-mesylate for all patients with hypereosinophilic syndrome? 450
Induction of Apoptosis by Pyrrolobenzothiadiazepines (PBTDs) in cell lines and in 12 chronic myeloid leukaemia patients and imatinib-resistant 447
Pyrrolo[1,2-b][1,2,5]benzothiadiazepines (PBTDs): A New Class of Agents with High Apoptotic Activity in Chronic Myelogenous Leukemia K562 Cells and in Cells from Patients at Onset and Who Were Imatinib-Resistant. 443
Mitoxantrone in combination with etoposide and cytarabine for treatment of poor prognosis acute non lymphoid leukemia patients 436
High-dose ascorbate and arsenic trioxide selectively kill acute myeloid leukemia and acute promyelocytic leukemia blasts in vitro 434
Expression cDNA cloning of a novel oncogene with sequence similarity to regulators of small GTP-binding proteins 433
Complex and multifaceted therapy-related myeloid neoplasm following laryngeal cancer treated with Cisplatin and radiotherapy 430
Benzodiazepine derivatives and uses thereof in medical field 427
PYRROLO[1,2-b][1,2,5]BENZOTHIADIAZEPINES (PBTDs) induce apoptosis in K562 cells. 413
“Pyrrolo[1,2-b][1,2,5]benzothiadiazepines (PBTDs) induce apoptosis in primari chronic myelogenous leukemic cells”. 403
Quantitative analysis of Fas and bcl-2 expression in hematopoietic precursors 402
Induction of Apoptosis by Pyrrolobenzothiadiazepines (PBTDs) in cell lines and in 12 chronic myeloid leukaemia patients and imatinib-resistant 401
Concomitant transformation of monoclonal gammopathy of undetermined significance to multiple myeloma and of essential thrombocythemia to acute biphenotypic leukemia 37 years after initial diagnosis 396
Positive selection of CD34+ cells by immunoadsorption: factors affecting the final yield and hematopoietic recovery in patients with hematological malignancies and solid tumors 392
null 385
Nucleophosmin/B26 regulates PTEN through interaction with HAUSP in acute myeloid leukemia 382
Long-term hematological response in a patient with 5q- syndrome after suspension of lenalidomide therapy and further improvement with deferasirox therapy 377
PML/RARA inhibits expression of HSP90 and its target AKT 368
Spontaneous apoptosis and proliferation detected by BCL-2 and CD71 proteins are important progression indicators within ZAP-70 negative chronic lymphocytic leukemia. 365
Sarcoma di Kaposi e neoplasie linfoproliferative 348
Level of minimal residual disease after consolidation therapy predicts outcome in acute myeloid leukemia 346
[Current aspects of treatment of multiple myeloma] 345
Acute promyelocytic Leukemia: Update on the mechanisms of leukemogenesis, resistance and on innovative treatment strategies 283
PML/RARa interferes with NRF2 transcriptional activity increasing the sensitivity to ascorbate of acute promyelocytic leukemia cells 248
Absence of FGFR3-TACC3 rearrangement in hematological malignancies with numerical chromosomal alteration 182
MCL1 regulates AML cells metabolism via direct interaction with HK2. Metabolic signature at onset predicts overall survival in AMLs' patients 138
Ascorbate Plus Buformin in AML: A Metabolic Targeted Treatment 126
NPM1 mutated, BCR-ABL1 positive myeloid neoplasms: review of the literature 118
Decitabine treatment of multiple extramedullary acute myeloid leukemia involvements after essential thrombocytemia transformation. 116
Decitabine as salvage therapy for primary induction failure of acute myeloid leukemia. 105
Acute Myeloid Leukemia in Older Patients: From New Biological Insights to Targeted Therapies 104
PLZF-RARΑ ENHANCES METABOLIC PLASTICITY AND ROS SCAVENGING IN AML CELLS 103
PML::RARα+ myeloid cells display metabolic alterations that can be targeted to treat resistant/relapse acute promyelocytic leukemias 81
Venetoclax and new BCL-2 inhibitors in acute myeloid leukemia 70
Molecular Targets of Oxidative Stress: Focus on Nuclear Factor Erythroid 2–Related Factor 2 Function in Leukemia and Other Cancers 57
Sustained resolution of anemia without any treatment after excessive therapeutic response to human recombinant erythropoietin in three patients with myelodysplastic syndromes 53
Correction: Niscola et al. Acute Myeloid Leukemia in Older Patients: From New Biological Insights to Targeted Therapies. Curr. Oncol. 2024, 31, 6632–6658 48
Metabolic Signature of FLT3-Mutated AML: Clinical and Therapeutic Implications 45
The Management of Membranous Glomerulopathy in Allogeneic Stem Cells Transplantation: Updated Literature 42
Sustained resolution of anemia without any treatment after excessive therapeutic response to human recombinant erythropoietin in three patients with myelodysplastic syndromes 40
Totale 14.219
Categoria #
all - tutte 33.351
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.351


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022355 0 55 8 25 11 24 26 13 22 25 24 122
2022/2023513 53 46 25 49 50 111 39 24 57 13 28 18
2023/2024202 29 7 17 8 25 65 3 1 3 5 6 33
2024/2025870 18 243 100 66 29 51 72 33 105 47 57 49
2025/20261.897 141 71 208 159 185 77 278 195 203 202 84 94
2026/2027206 132 74 0 0 0 0 0 0 0 0 0 0
Totale 14.219